Meeting Prep: Health Evolution Roundtable
Thu Feb 12, 2:00-3:00 PM ET (11:00 AM-12:00 PM PT) | Zoom
Session Topic
Closing the Affordability Gap: From Financial Toxicity to Consumer-Centered SolutionsDiscussion Leaders
| Name | Role | Notes |
|---|---|---|
| Steve Klasko, MD | Executive in Residence, General Catalyst; former CEO, Jefferson Health | Co-wrote UnHealthcare with GC CEO Hemant Taneja. Advocates "health assurance" -- proactive, personal, affordable. Built Jefferson from $1.8B to $9B. Chairs DocGo board. |
| Stephen Curtis, PhD | Interim VP Innovation & Impact Investing, American Cancer Society; MD, ACS BrightEdge LLC | Cancer-focused impact investing. Potential Patient Finder alignment (oncology trial recruitment). |
| Mike Roaldi | President, Cityblock Health | Community-based care for underserved populations. Medicaid/dual-eligible focused. |
Co-Chairs (Key Contacts in the Room)
| Name | Role | Strategic Value |
|---|---|---|
| Glen Tullman | CEO, Transcarent | Founded Livongo ($18.5B exit). Just launched WayFinding 2.0 "agentic AI" at CES 2026. Serves 1,700 employers, 35 health plans. Potential competitor OR partner. |
| Susannah Fox | Board, Cambia Health Solutions; former CTO, HHS | Health data/patient advocacy legend. Good to know. |
| Geeta Nayyar, MD | CMO, Technologist, WSJ Bestselling Author | Digital health thought leader. |
| Sara Vaezy | Chief Transformation Officer, Providence | Major health system. Providence = potential Patient Finder customer for health system channel. |
Strategic Positioning for Daniel
- DO NOT pitch. This is a confidential peer discussion. No AI notetaking allowed. Build relationships.
- Listening mode. Understand how these leaders think about consumer-centric care. Identify who might be a future partner or customer.
- Key angle if asked: Ada's Patient Finder addresses affordability by catching disease early (before it becomes expensive). Undiagnosed = financial toxicity later.
- Glen Tullman watch: Transcarent's WayFinding 2.0 does symptom triage with "agentic AI." Different from Patient Finder (they're employer-focused, we're pharma-focused), but worth understanding his framing of AI in healthcare.
- Stephen Curtis / ACS: If oncology comes up, Patient Finder's Trial Finder product is directly relevant. ACS BrightEdge does impact investing in cancer innovation.
- Sara Vaezy / Providence: Health systems are a secondary channel for Patient Finder. Worth a side conversation.
Rules of Engagement
- Closed community, invitation only
- No AI notetaking or recording
- Confidential environment
- Do not share Zoom link
Meeting Logistics
- Zoom: https://healthevolution.zoom.us/j/84218096977
- Meeting ID: 842 1809 6977
- Note: Conflicts with Strategy Block (2-5 PM ET). Roundtable ends at 3 PM, then can pivot to strategy work.